Senior Director of AI-driven Drug Discovery at AstraZeneca, one of the largest pharmaceutical companies globally. He is currently team leader in computational chemistry within the Discovery Sciences, Chemistry Innovation Centre. His research interests include cheminformatics, molecular modeling, phenotypic screening, target deconvolution, and open innovation. He is currently Associate Director in MolecularAI within the Discovery Sciences, Hit Discovery department. His research interests include Artificial intelligence, Machine learning in particular deep learning, Cheminformatics, Molecular modelling and Open Innovation.